SELL and neoplasm: In B16-OVA expressing tumours, the administration of blocking antibodies targeted against L-selectin (which recognizes sulfated sialomucins displayed on HEVs) or anti-CCR7 (activates LFA-1 leading to lymphocyte arrest) prevented lymphocyte infiltration into tumours [14].